Citations

Clear

1526 citation(s) found for "Sun, D".

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis
Deol, Abhinav , Sengsayadeth, Salyka, Ahn, Kwang Woo , Wang, Hailin , Aljurf, Mahmoud , Antin, Joseph H. , Cahn, Jean‐Yves , Camitta, Bruce, Chen, Yi‐Bin , Ganguly, Siddhartha , Inamoto, Yoshihiro , Jagasia, Madan , Kamble, Rammurti T., Koreth, John , Litzow, Mark R. , Marks, David I. , Olsson, Richard F. , Rowe, Jacob M. , Saad, Ayman , Sabloff, Mitchell , Schouten, Harry C. , Shea, Thomas C., Soiffer, Robert J. , Uy, Geoffrey L. , Waller, Edmund K. , Wiernik, Peter H. , Wirk, Baldeep , Woolfrey, Ann E. , Bunjes, Donald , Weisdorf, Dan, Khoury, H. Jean , Saber, Wael , Weisdorf, Daniel J. , Battiwalla, Minoo , Bornhäuser, Martin , Camitta, Bruce M., Cutler, Corey S. , Gale, Robert Peter , Hamadani, Mehdi , Lazarus, Hillard M. , Liesveld, Jane L. , Nishihori, Taiga , Reshef, Ran , Devine, Steven M. , Lima, Marcos de , Sandmaier, Brenda M , Saad, Ayman , Olsson, Richard F , Waller, Edmund K , Weisdorf, Dan , Uy, Geoffrey , Sabloff, Mitchell

Mayo Clinic

Cancer | June 17, 2016 | Volume: 122 | Issue: 19 | Pages: 3005-3014

10.1002/cncr.30140 | PMID 27315441 Get It

BACKGROUNDPatients with FMS like tyrosine kinase 3 (FLT3)‐mutated acute myeloid leukemia (AML) have a poor prognosis and are referred for early allogeneic hematopoietic stem cell transplantation (HCT).METHODSData from the Center for International Blood and Marrow Transplant Research (CIBMTR) were used to evaluate 511 adult patients with de novo AML who underwent HCT during 2008 through 2011 to determine whether FLT3 mutations had an impact on HCT outcomes.RESULTSIn total, 158 patients (31%) had FLT3 mutations. Univariate and multivariate analyses revealed an increased risk of relapse at 3 years in the FLT3 mutated group compared with the wild‐type (WT) group (38% [95% confidence interval (CI), 30%‐45%] vs 28% [95% CI, 24%‐33%]; P = .04; relative risk, 1.60 [95% CI, 1.15‐2.22]; P = .0048). However, FLT3 mutation status was not significantly associated with nonrelapse mortality, leukemia‐free survival, or overall survival. Although more patients in the FLT3 mutated group died from relapsed primary disease compared with those in the WT group (60% vs 46%), the 3‐year overall survival rate was comparable for the 2 groups (mutated group: 49%; 95% CI, 40%‐57%; WT group: 55%, 95% CI, 50%‐60%; P = .20).CONCLUSIONSThe current data indicate that FLT3 mutation status did not adversely impact overall survival after HCT, and about 50% of patients with this mutation who underwent HCT were long‐term survivors. Cancer 2016;122:3005‐3014. © 2016 American Cancer Society.
A modified fuzzy C-means method for segmenting MR images using non-local information
Li, Chungang, Sun, Lining , Mutic, Sasa , Hu, Yanle , Feng, Yuan , Guo, Hao, Zhang, Hongmiao , Ji, Songbai

Mayo Clinic

Technology and Health Care | June 17, 2016 | Volume: 24 | Issue: s2 | Pages: S785-S793

10.3233/thc-161208 | PMID 27177108 Get It

A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia
Luskin, Marlise R. , Gimotty, Phyllis A. , Smith, Catherine , Loren, Alison W. , Harrison, Jenna , Sun, Zhuoxin , Tallman, Martin S. , Paietta, Elisabeth , Litzow, Mark R. , Melnick, Ari , Levine, Ross L. , Fernández, Hugo F. , Luger, Selina M. , Wertheim, Gerald , Luskin, Marlise R , Figueroa, María E. , Carroll, Martin P , Master, Stephen R. , Melnick, Ari

Mayo Clinic

JCI Insight | June 15, 2016 | Volume: 1 | Issue: 9 | Pages: No page available

10.1172/jci.insight.87323 | PMID 27446991 Get It

BACKGROUND. Variable response to chemotherapy in acute myeloid leukemia (AML) represents a major treatment challenge. Clinical and genetic features incompletely predict outcome. The value of clinical epigenetic assays for risk classification has not been extensively explored. We assess the prognostic implications of a clinical assay for multilocus DNA methylation on adult patients with de novo AML. METHODS. We performed multilocus DNA methylation assessment using xMELP on samples and calculated a methylation statistic (M-score) for 166 patients from UPENN with de novo AML who received induction chemotherapy. The association of M-score with complete remission (CR) and overall survival (OS) was evaluated. The optimal M-score cut-point for identifying groups with differing survival was used to define a binary M-score classifier. This classifier was validated in an independent cohort of 383 patients from the Eastern Cooperative Oncology Group Trial 1900 (E1900; NCT00049517). RESULTS. A higher mean M-score was associated with death and failure to achieve CR. Multivariable analysis confirmed that a higher M-score was associated with death ( P = 0.011) and failure to achieve CR ( P = 0.034). Median survival was 26.6 months versus 10.6 months for low and high M-score groups. The ability of the M-score to perform as a classifier was confirmed in patients ≤ 60 years with intermediate cytogenetics and patients who achieved CR, as well as in the E1900 validation cohort. CONCLUSION. The M-score represents a valid binary prognostic classifier for patients with de novo AML. The xMELP assay and associated M-score can be used for prognosis and should be further investigated for clinical decision making in AML patients.
Multiple-level validation identifiesPARK2in the development of lung cancer and chronic obstructive pulmonary disease
Lee, SeungBaek, Deng, Bo , Kim, Jung-Jin, Sun, Zhifu , Wampfler, Jason A. , Cunningham, Julie M. , Wu, Yanhong , Aubry, Marie-Christine, Wendt, Chris H. , Biterman, Peter, Lee, Seung Baek , She, Jun, Kim, JungJin, de Andrade, Mariza, Na, Jie , Lee, SeungBaek , She, Jun , Andrade, Mariza de , Limper, Andrew H. , Yang, Ping , Lou, Zhenkun , Sun, Zhifu , Wendt, Chris H , Lee, Seung Baek

Mayo Clinic

Oncotarget | June 13, 2016 | Volume: 7 | Issue: 28 | Pages: 44211-44223

10.18632/oncotarget.9954 | PMID 27329585 Get It

In vivo myosin step-size from zebrafish skeletal muscle
Burghardt, Thomas P. , Ajtai, Katalin , Sun, Xiaojing , Takubo, Naoko, Wang, Yihua

Mayo Clinic

Open Biology | May 25, 2016 | Volume: 6 | Issue: 5 | Pages: 160075

10.1098/rsob.160075 | PMID 27249818 Get It

Muscle myosins transduce ATP free energy into actin displacement to power contraction. In vivo , myosin side chains are modified post-translationally under native conditions, potentially impacting function. Single myosin detection provides the ‘bottom-up’ myosin characterization probing basic mechanisms without ambiguities inherent to ensemble observation. Macroscopic muscle physiological experimentation provides the definitive ‘top-down’ phenotype characterizations that are the concerns in translational medicine. In vivo single myosin detection in muscle from zebrafish embryo models for human muscle fulfils ambitions for both bottom-up and top-down experimentation. A photoactivatable green fluorescent protein (GFP)-tagged myosin light chain expressed in transgenic zebrafish skeletal muscle specifically modifies the myosin lever-arm. Strychnine induces the simultaneous contraction of the bilateral tail muscles in a live embryo, causing them to be isometric while active. Highly inclined thin illumination excites the GFP tag of single lever-arms and its super-resolution orientation is measured from an active isometric muscle over a time sequence covering many transduction cycles. Consecutive frame lever-arm angular displacement converts to step-size by its product with the estimated lever-arm length. About 17% of the active myosin steps that fall between 2 and 7 nm are implicated as powerstrokes because they are beyond displacements detected from either relaxed or ATP-depleted (rigor) muscle.
O-linked N -acetylglucosamine transferase (OGT) interacts with the histone chaperone HIRA complex and regulates nucleosome assembly and cellular senescence
Lee, Jong-Sun, Zhang, Zhiguo , Zhang, Zhiguo

Mayo Clinic

Proceedings of the National Academy of Sciences | May 24, 2016 | Volume: 113 | Issue: 23 | Pages: No page available

10.1073/pnas.1600509113 | PMID 27217568 Get It

Significance Nucleosome assembly is regulated at multiple levels to impact distinct cellular processes. Mutations in factors involved in nucleosome assembly, such as histone chaperones and histone variants, result in genome instability and gene expression defects that, in turn, promote the development of human disease including cancer and aging. Therefore, it is important to determine how nucleosome assembly of H3.3 is regulated. Our findings demonstrate a role for O-linked N -acetylglucosamine (GlcNAc) transferase in regulating H3.3 deposition/exchange and establish the O-GlcNAc modification of HIRA as a previously unidentified mechanism regulating nucleosome assembly of H3.3 and cellular senescence.
Functional Plasticity of Adipose-Derived Stromal Cells During Development of Obesity
Zhu, Xiang-Yang, Ma, Shuangtao , Eirin, Alfonso , Woollard, John R. , Hickson, LaTonya J. , Sun, Dong , Lerman, Lilach O. , Lerman, Amir , Hickson, LaTonya J , Eirin, Alfonso

Mayo Clinic

Stem Cells Translational Medicine | May 14, 2016 | Volume: 5 | Issue: 7 | Pages: 893-900

10.5966/sctm.2015-0240 | PMID 27177576 Get It

Abstract Obesity is a major risk factor for a number of chronic diseases, including diabetes, cardiovascular diseases, and cancer. Expansion of the adipose mass requires adipocyte precursor cells that originate from multipotent adipose-derived stromal cells (ASCs), which in turn also participate in repair activities. ASC function might decline in a disease milieu, but it remains unclear whether ASC function varies during the development of obesity. We tested the hypothesis that microenvironmental inflammatory changes during development of metabolic disorders in obesity affect ASC function. Domestic pigs were fed with an atherogenic (n = 7) or normal (n = 7) diet for 16 weeks. Abdominal adipose tissue biopsies were collected after 8, 12, and 16 weeks of diet for ASC isolation and immunohistochemistry of in situ ASCs and tumor necrosis factor-α (TNF-α). Longitudinal changes in proliferation, differentiation, and anti-inflammatory functions of ASCs were assessed. At 16 weeks, upregulated TNF-α expression in adipose tissue from obese pigs was accompanied by increased numbers of adipocyte progenitors (CD24+/CD34+) in adipose tissue and enlarged adipocyte size. In vitro, ASCs from obese pigs showed enhanced adipogenic and osteogenic propensity, which was abolished by anti-TNF-α treatment, whereas lean ASCs treated with TNF-α showed enhanced adipogenesis. Furthermore, obese ASCs showed increased senescence compared with lean ASCs, whereas their immunomodulatory capacity was preserved. Adipose tissue inflammation promotes an increase in resident adipocyte progenitors and upregulated TNF-α enhances ASC adipogenesis. Thus, adipose tissue anti-inflammatory strategies might be a novel target to attenuate obesity and its complications. Significance Adipose-derived stromal cell (ASC) function might decline in a disease milieu, but it remains unclear whether ASC function varies during the development of obesity. This study tested the hypothesis that microenvironmental inflammatory changes during development of metabolic disorders in obesity affect ASC function. It was found that ASCs show increased propensity for differentiation into adipocytes, which is partly mediated by upregulated tumor necrosis factor-α (TNF-α), likely in their adipose tissue microenvironment. Furthermore, TNF-α magnified obese ASC senescence, although it did not regulate their anti-inflammatory properties. Thus, adipose tissue inflammation might be a novel therapeutic target to avert ASC maldifferentiation and senescence.
Testing of evaluation bias for progression free survival endpoint in oncology clinical trials
Sun, Yan , Wu, Wenting , Sun, Yan , Sargent, Daniel J , Sargent, Daniel J.

Mayo Clinic

Statistics in Medicine | April 19, 2016 | Volume: 35 | Issue: 22 | Pages: 3923-3932

10.1002/sim.6963 | PMID 27089832 Get It

Progression‐free survival is an increasingly popular end point in oncology clinical trials. A complete blinded independent central review (BICR) is often required by regulators in an attempt to reduce the bias in progression‐free survival (PFS) assessment. In this paper, we propose a new methodology that uses a sample‐based BICR as an audit tool to decide whether a complete BICR is needed. More specifically, we propose a new index, the differential risk, to measure the reading discordance pattern, and develop a corresponding hypothesis testing procedure to decide whether the bias in local evaluation is acceptable. Simulation results demonstrate that our new index is sensitive to the change of discordance pattern; type I error is well controlled in the hypothesis testing procedure, and the calculated sample size provides the desired power. Copyright © 2016 John Wiley & Sons, Ltd.
BLM promotes the activation of Fanconi Anemia signaling pathway
Panneerselvam, Jayabal, Che, Raymond , Fei, Peiwen, Wang, Hong , Zhang, Jun , Yu, Kai

Mayo Clinic

Oncotarget | April 12, 2016 | Volume: 7 | Issue: 22 | Pages: 32351-32361

10.18632/oncotarget.8707 | PMID 27083049 Get It